Please try another search
Cardiovascular Systems (CSII) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.01 per share a year...
Cirrus Logic (CRUS) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $1.59 per share a year ago. These figures...
Duke Realty (DRE) came out with quarterly funds from operations (FFO) of $0.35 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.30 per share a year ago. These figures...
Facebook (NASDAQ:FB) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $2.17 per share. This compares to earnings of $2.20 per share a year ago. These...
Microsoft (MSFT) came out with quarterly earnings of $1.10 per share, beating the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $0.96 per share a year ago. These figures...
Tetra Tech (TTEK) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.65 per share a year ago. These figures...
Simulations Plus, Inc. (NASDAQ:SLP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day...
Marine Products Corporation (NYSE:MPX) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day...
Xperi Corporation (NASDAQ:XPER) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. Recently, the 50...
Shares of Alibaba (NYSE:BABA) surged over 6% Wednesday despite posting its slowest quarterly revenue growth in three years before the opening bell. The Chinese e-commerce powerhouse did see some...
Roche Holding (SIX:ROG) AG (OTC:RHHBY) announced that it is discontinuing two phase III studies on the investigational anti-beta-amyloid molecule, crenezumab in people with early (prodromal to mild)...
A wide range of macroeconomic and geopolitical tensions have induced volatility in U.S. equity markets since the back half of last year, resulting in unpredictability in stock price movement. The...
Based in Switzerland, Novartis AG (NYSE:NVS) is one of the leaders in health care solutions with a wide array of drugs and services. The company has a strong oncology portfolio of drugs like...
It's difficult to write about Tesla (NASDAQ:TSLA) without pointing out how precarious the business remains. To be fair, this isn't news—the electric automobile manufacturer has been living on...
Dillard’s Inc. (NYSE:DDS) is an appropriate investment option, as it is well poised for growth on the back of solid prospects such as inventory management initiatives, increased trendy product...